Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP)

Hatabu, 2019, Interstitial lung abnormality: recognition and perspectives, Radiology, 291, 1, 10.1148/radiol.2018181684 Hatabu, 2020, Interstitial lung abnormalities detected incidentally on CT: a position paper from the Fleischner Society, Lancet Respir. Med., 8, 726, 10.1016/S2213-2600(20)30168-5 Katzenstein, 1998, Idiopathic pulmonary fibrosis clinical relevance of pathologic classification clinical features of the idiopathic interstitial pneumonias, Am. J. Respir. Crit. Care Med., 157, 1301, 10.1164/ajrccm.157.4.9707039 American Thoracic Society, 2002, American thoracic Society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias, Am. J. Respir. Crit. Care Med., 165, 277, 10.1164/ajrccm.165.2.ats01 Hino, 2020, Spectrum of pulmonary fibrosis from interstitial lung abnormality to usual interstitial pneumonia: importance of identification and quantification of traction bronchiectasis in patient management, Korean J. Radiol., 21 Hunninghake, 2001, Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis, Am. J. Respir. Crit. Care Med., 164, 193, 10.1164/ajrccm.164.2.2101090 Rosas, 2007, Early interstitial lung disease in familial pulmonary fibrosis, Am. J. Respir. Crit. Care Med., 176, 698, 10.1164/rccm.200702-254OC Copley, 2009, Lung morphology in the elderly: comparative CT study of subjects over 75 years old versus those under 55 years old, Radiology, 251, 566, 10.1148/radiol.2512081242 Gochuico, 2008, Progressive preclinical interstitial lung disease in rheumatoid arthritis, Arch. Intern. Med., 168, 159, 10.1001/archinternmed.2007.59 Lederer, 2009, Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study, Am. J. Respir. Crit. Care Med., 180, 407, 10.1164/rccm.200812-1966OC Washko, 2010, Identification of early interstitial lung disease in smokers from the COPDGene study, Acad. Radiol., 17, 48, 10.1016/j.acra.2009.07.016 Tsushima, 2010, The radiological patterns of interstitial change at an early phase: over a 4-year follow-up, Respir. Med., 104, 1712, 10.1016/j.rmed.2010.05.014 Washko, 2011, Lung volumes and emphysema in smokers with interstitial lung abnormalities, N. Engl. J. Med., 364, 897, 10.1056/NEJMoa1007285 Sverzellati, 2011, Interstitial lung diseases in a lung cancer screening trial, Eur. Respir. J., 38, 392, 10.1183/09031936.00201809 Jin, 2013, Interstitial lung abnormalities in a CT lung cancer screening population : Prevalence and progression rate, Radiology, 268, 563, 10.1148/radiol.13120816 Hunninghake, 2013, MUC5B promoter polymorphism and interstitial lung abnormalities, N. Engl. J. Med., 368, 2192, 10.1056/NEJMoa1216076 Araki, 2016, Development and progression of interstitial lung abnormalities in the Framingham Heart Study, Am. J. Respir. Crit. Care Med., 194, 1517, 10.1164/rccm.201512-2523OC Putman, 2014, Genetics and early detection in idiopathic pulmonary fibrosis, Am. J. Respir. Crit. Care Med., 189, 770, 10.1164/rccm.201312-2219PP Putman, 2017, The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes, Eur. Respir. J., 50, 10.1183/13993003.00537-2017 Doyle, 2012, Interstitial lung abnormalities and reduced exercise capacity, Am. J. Respir. Crit. Care Med., 185, 756, 10.1164/rccm.201109-1618OC Podolanczuk, 2016, High attenuation areas on chest computed tomography in communitydwelling adults: the MESA study, Eur. Respir. J., 48, 1442, 10.1183/13993003.00129-2016 Putman, 2016, Association between interstitial lung abnormalities and all-cause mortality, JAMA, 315, 672, 10.1001/jama.2016.0518 Lynch, 2018, Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper, Lancet Respir. Med., 6, 138, 10.1016/S2213-2600(17)30433-2 Edey, 2011, Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality, Eur. Radiol., 21, 1586, 10.1007/s00330-011-2098-2 Putman, 2019, Imaging patterns are associated with interstitial lung abnormality progression and mortality, Am. J. Respir. Crit. Care Med., 200, 175, 10.1164/rccm.201809-1652OC Hida, 2020, Traction Bronchiectasis/Bronchiolectasis is associated with interstitial lung abnormality mortality, Eur. J. Radiol., 129, 10.1016/j.ejrad.2020.109073 Hoyer, 2018, Interstitial lung abnormalities are associated with increased mortality in smokers, Respir. Med., 136, 77, 10.1016/j.rmed.2018.02.001 Hino, 2020, Progression of traction Bronchiectasis/bronchiolectasis in interstitial lung abnormalities is associated with increased all-cause mortality: age Gene/Environment susceptibility-reykjavik study, Eur. J. Radiol. Open Liebow, 1969, The interstitial pneumonias, 102 Epler, 1985, Bronchiolitis obliterans organizing pneumonia, N. Engl. J. Med., 312, 152, 10.1056/NEJM198501173120304 Davison, 1983, Cryptogenic organizing pneumonitis, Q. J. Med., 52, 382 Lee, 1994, Cryptogenic organizing pneumonia: CT findings in 43 patients, Am. J. Roentgenol, 162, 543, 10.2214/ajr.162.3.8109493 Nicholson, 2008, Interstitial pneumonias, 695 Choi, 2005, Giant cell interstitial pneumonia: high-resolution CT and pathologic findings in four adult patients, Am. J. Roentgenol., 184, 268, 10.2214/ajr.184.1.01840268 Katzenstein, 1994, Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance, Am. J. Surg. Pathol., 18, 136, 10.1097/00000478-199402000-00003 Myers, 1987, Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases, Am. Rev. Respir. Dis., 135, 880, 10.1164/arrd.1987.135.4.880 Yousem, 1989, Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia, Mayo Clin. Proc., 64, 1373, 10.1016/S0025-6196(12)65379-8 Katzenstein, 1986, Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study, Am. J. Surg. Pathol., 10, 256, 10.1097/00000478-198604000-00004 Travis, 2013, An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias, Am. J. Respir. Crit. Care Med., 188, 733, 10.1164/rccm.201308-1483ST Travis, 2008, Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project, Am. J. Respir. Crit. Care Med., 177, 1338, 10.1164/rccm.200611-1685OC Kim, 2006, Classification and natural history of the idiopathic interstitial pneumonias, Proc. Am. Thorac. Soc., 3, 285, 10.1513/pats.200601-005TK Flaherty, 2001, Histopathologic variability in usual and nonspecific interstitial pneumonias, Am. J. Respir. Crit. Care Med., 164, 1722, 10.1164/ajrccm.164.9.2103074 Park, 1995, Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients, Radiology, 195, 645, 10.1148/radiology.195.3.7753988 Kim, 1998, Nonspecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings, Am. J. Roentgenol., 171, 1645, 10.2214/ajr.171.6.9843306 Kim, 1999, Nonspecific interstitial pneumonia with fibrosis: serial high-resolution CT findings with functional correlation, Am. J. Roentgenol., 173, 949, 10.2214/ajr.173.4.10511155 Shin, 2008, Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study, Radiology, 249, 328, 10.1148/radiol.2483071378 Jeong, 2005, Usual interstitial pneumonia and non-specific interstitial pneumonia: serial thin-section CT findings correlated with pulmonary function, Korean J. Radiol., 6, 143, 10.3348/kjr.2005.6.3.143 Silva, 2008, Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT, Radiology, 246, 288, 10.1148/radiol.2453061881 Lee, 2012, High-resolution CT findings in fibrotic idiopathic interstitial pneumonias with little honeycombing: serial changes and prognostic implications, AJR Am. J. Roentgenol., 199, 982, 10.2214/AJR.11.8192 Nunes, 2015, Nonspecific interstitial pneumonia: survival is influenced by the underlying cause, Eur. Respir. J., 45, 746, 10.1183/09031936.00148613 Yoo, 2021, Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): evolving concept of CT findings, pathology and management, Eur. J. Radiol. Open, 8, 10.1016/j.ejro.2020.100311 Arakawa, 2003, Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation, Chest, 123, 1096, 10.1378/chest.123.4.1096 MacDonald, 2001, Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT, Radiology, 221, 600, 10.1148/radiol.2213010158 Johkoh, 1999, Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients, Radiology, 211, 555, 10.1148/radiology.211.2.r99ma01555 Sumikawa, 2006, Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients, Radiology, 241, 258, 10.1148/radiol.2411050928 Sumikawa, 2014, Pathologically proved nonspecific interstitial pneumonia: CT pattern analysis as compared with usual interstitial pneumonia CT pattern, Radiology, 272, 549, 10.1148/radiol.14130853 Silva, 2008, Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time, Radiology, 247, 251, 10.1148/radiol.2471070369 Gruden, 2013, UIP diagnosed at surgical lung biopsy, 2000-2009: HRCT patterns and proposed classification system, AJR Am. J. Roentgenol., 200, 458, 10.2214/AJR.12.9437 Sumikawa, 2008, Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival, Am. J. Respir. Crit. Care Med., 177, 433, 10.1164/rccm.200611-1696OC Raghu, 2018, Diagnosis of idiopathic pulmonary fibrosis an official ATS/ERS/JRS/ALAT clinical practice guideline, Am. J. Respir. Crit. Care Med., 198, e44, 10.1164/rccm.201807-1255ST Travis, 2000, Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns, Am. J. Surg. Pathol., 24, 19, 10.1097/00000478-200001000-00003 Johkoh, 2021, Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner society, Radiology, 298, 550, 10.1148/radiol.2021203427 Johkoh, 2021, Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner society, Chest, 10.1016/j.chest.2020.11.027 Miller, 2018, Histopathology of interstitial lung abnormalities in the context of lung nodule resections, Am. J. Respir. Crit. Care Med., 197, 955, 10.1164/rccm.201708-1679LE Hung, 2019, Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions, Hum. Pathol., 86, 93, 10.1016/j.humpath.2019.01.002 Kawabata, 2008, Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course, Histopathology, 53, 707, 10.1111/j.1365-2559.2008.03183.x Yamada, 2013, Airspace enlargement with fibrosis shows characteristic histology and immunohistology different from usual interstitial pneumonia, nonspecific interstitial pneumonia and centrilobular emphysema, Pathol. Int., 63, 206, 10.1111/pin.12054 Itoh, 1993, Diffuse lung disease: pathologic basis for the high-resolution computed tomography findings, J. Thorac. Imaging, 8, 176, 10.1097/00005382-199322000-00003 Oldham, 2018, Underreporting of interstitial lung abnormalities on lung Cancer screening computed tomography, Ann. Am. Thorac. Soc., 15, 764, 10.1513/AnnalsATS.201801-053RL Wright, 2011, Fibrosis with emphysema, Histopathology, 58, 517, 10.1111/j.1365-2559.2010.03648.x Nicholson, 2004, Inter-observer variation between pathologists in diffuse parenchymal lung disease, Thorax, 59, 500, 10.1136/thx.2003.011734 Watadani, 2013, Interobserver variability in the CT assessment of honeycombing in the lungs, Radiology, 266, 936, 10.1148/radiol.12112516 Walsh, 2015, Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease, BMC Med., 13, 241, 10.1186/s12916-015-0479-0 Staats, 2015, A comparative study of honeycombing on high resolution computed tomography with histologic lung remodeling in explants with usual interstitial pneumonia, Pathol. Res. Pract., 211, 55, 10.1016/j.prp.2014.08.013 Chilosi, 2002, Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63, Lab. Invest., 82, 1335, 10.1097/01.LAB.0000032380.82232.67 Piciucchi, 2016, From “traction bronchiectasis” to honeycombing in idiopathic pulmonary fibrosis: a spectrum of bronchiolar remodeling also in radiology?, BMC Pulm. Med., 16, 87, 10.1186/s12890-016-0245-x Salisbury, 2019, Hypersensitivity pneumonitis: radiologic phenotypes are associated with distinct survival time and pulmonary function trajectory, Chest, 155, 699, 10.1016/j.chest.2018.08.1076 Walsh, 2012, Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants, Eur. Radiol., 22, 1672, 10.1007/s00330-012-2427-0 Park, 2007, Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes, Am. J. Respir. Crit. Care Med., 175, 705, 10.1164/rccm.200607-912OC Navaratnam, 2011, Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis?, Respir. Med., 105, 1925, 10.1016/j.rmed.2011.08.015 Kim, 2002, Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings, Radiographics, 22, S151, 10.1148/radiographics.22.suppl_1.g02oc04s151 Oliveira, 2020, Connective tissue disease-associated interstitial lung disease, Pulmonology Kim, 2009, Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern, Chest, 136, 1397, 10.1378/chest.09-0444 Tomassetti, 2016, Nonspecific interstitial pneumonia: what is the optimal approach to management?, Semin. Respir. Crit. Care Med., 37, 378, 10.1055/s-0036-1583176 Tashkin, 2006, Cyclophosphamide versus placebo in scleroderma lung disease, N. Engl. J. Med., 354, 2655, 10.1056/NEJMoa055120 Hoyles, 2006, A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma, Arthritis Rheum., 54, 3962, 10.1002/art.22204 Tashkin, 2016, Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial, Lancet Respir. Med., 4, 708, 10.1016/S2213-2600(16)30152-7 Gutsche, 2012, Connective tissue disease-associated interstitial lung disease: a review, Curr. Respir. Care Rep., 1, 224, 10.1007/s13665-012-0028-7 Solomon, 2015, Connective tissue disease-associated interstitial lung disease: a focused review, J. Intensive Care Med., 30, 392, 10.1177/0885066613516579 Park, 2009, Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia, Eur. Respir. J., 33, 68, 10.1183/09031936.00158507 Lee, 2012, Treatment response and long term follow-up results of nonspecific interstitial pneumonia, J. Korean Med. Sci., 27, 661, 10.3346/jkms.2012.27.6.661 Richeldi, 2014, Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis, N. Engl. J. Med., 370, 2071, 10.1056/NEJMoa1402584 King, 2014, A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis, N. Engl. J. Med., 370, 2083, 10.1056/NEJMoa1402582 Distler, 2019, Nintedanib for systemic sclerosis-associated interstitial lung disease, N. Engl. J. Med., 380, 2518, 10.1056/NEJMoa1903076 Flaherty, 2019, Nintedanib in progressive fibrosing interstitial lung diseases, N. Engl. J. Med., 381, 1718, 10.1056/NEJMoa1908681 Behr, 2017, Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial, BMC Pulm. Med., 17, 122, 10.1186/s12890-017-0462-y